Clinical trial

A Study of LY3532226 in Participants With Obesity

NCT06557356

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-08-16

PhasePHASE1

Study timeline

Study start (actual)2024-08-16Date precision: day

Registry last updated2026-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

LY3532226DRUG

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

DallasTexas, United States1 MadisonWisconsin, United States1 SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06557356 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.